Global Enoxaparin Sodium Market: USD 3,027 Million in 2024 to USD 5,111 Million by 2032, Growing at a CAGR of 7.7%

Global Enoxaparin Sodium Market is experiencing strong growth driven by rising cases of thrombotic disorders, increasing surgical procedures, and expanding use in acute coronary syndrome (ACS) management. Enoxaparin Sodium, a widely used low molecular weight heparin (LMWH), offers predictable anticoagulation, reduced monitoring needs, and enhanced safety over traditional heparin. Its applications span DVT and PE prevention, pregnancy-related thrombophilia, oncology-related VTE, and hemodialysis care. Market expansion is supported by improving healthcare infrastructure, growing adoption of standardized thromboprophylaxis protocols, and rising awareness in emerging regions. Despite biosimilar competition and regulatory challenges, opportunities remain strong across developing markets and innovative delivery systems